BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19487876)

  • 1. Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas.
    Palma L
    Neurosurgery; 2009 Jun; 64(6):E1206; author reply E1206. PubMed ID: 19487876
    [No Abstract]   [Full Text] [Related]  

  • 2. Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas.
    Ketter R; Rahnenführer J; Henn W; Kim YJ; Feiden W; Steudel WI; Zang KD; Urbschat S
    Neurosurgery; 2008 Jan; 62(1):61-9; discussion 69-70. PubMed ID: 18300892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings.
    Al-Mefty O; Kadri PA; Pravdenkova S; Sawyer JR; Stangeby C; Husain M
    J Neurosurg; 2004 Aug; 101(2):210-8. PubMed ID: 15309910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of meningioma with frequent relapses and a hyperhaploid stemline.
    Rønne M; Poulsgård L; Elberg JJ
    Anticancer Res; 1988; 8(4):545-7. PubMed ID: 3178146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomas.
    Ketter R; Urbschat S; Henn W; Feiden W; Beerenwinkel N; Lengauer T; Steudel WI; Zang KD; Rahnenführer J
    Int J Cancer; 2007 Oct; 121(7):1473-80. PubMed ID: 17557299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Familial incidence of multiple, mainly spinal meningiomas].
    Wieczorek V; Tinschert K; Behrendt W; Besel R; Sölch O; Schreiber D; Hauschild R
    Nervenarzt; 1992 Apr; 63(4):244-6. PubMed ID: 1594091
    [No Abstract]   [Full Text] [Related]  

  • 8. Clear cell meningiomas: three case reports with genetic characterization and review of the literature.
    Ohba S; Sasaki H; Kimura T; Ikeda E; Kawase T
    Neurosurgery; 2010 Sep; 67(3):E870-1; discussion E871. PubMed ID: 20683214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of alkaline phosphatase activity predicts meningioma recurrence.
    Bouvier C; Liprandi A; Colin C; Giorgi R; Quilichini B; Metellus P; Figarella-Branger D
    Am J Clin Pathol; 2005 Aug; 124(2):252-8. PubMed ID: 16040297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Meningiomas: prognostic relevance of histopathologic and genetic markers].
    Kros JM; Wolbers JG
    Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2160-5. PubMed ID: 11727613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytogenetic aberrations in histologically benign infiltratively growing sphenoid wing meningiomas].
    Korshunov AG; Cherekaev VA; Bekiashev AKh; Sycheva RV
    Zh Vopr Neirokhir Im N N Burdenko; 2007; (4):11-5. PubMed ID: 18274131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of atypical meningioma with pulmonary metastases: a comparative cytogenetic analysis of chromosomes 1p and 22 and a review of the literature.
    Frydrychowicz C; Holland H; Hantmann H; Gradistanac T; Hoffmann KT; Mueller W; Meixensberger J; Krupp W
    Neuropathology; 2015 Apr; 35(2):175-83. PubMed ID: 25376227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution to malignancy in a recurrent meningioma: morphological and cytogenetic findings.
    Cerdá-Nicolás M; López-Ginés C; Barcia-Salorio J; Llombart-Bosch A
    Clin Neuropathol; 1998; 17(4):210-5. PubMed ID: 9707336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meningioma: a model of cytogenetic evolution in tumoral initiation and progresion].
    López-Ginés C; Gil-Benso R; Collado-Díaz M; Gregori-Romero M; Roldán P; Barberá J; Cerdá-Nicolás M
    Neurocirugia (Astur); 2003 Dec; 14(6):517-25. PubMed ID: 14710307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of folate metabolism-related gene polymorphisms in the development of meningiomas.
    Drakos SS; Anifantaki F; Zarros A; Liapi C
    Cancer Genomics Proteomics; 2010; 7(2):105-9. PubMed ID: 20335525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningiomas and neurofibromatosis for the oncologist.
    Schrell UM; Fahlbusch R; Adams EF
    Curr Opin Oncol; 1994 May; 6(3):247-53. PubMed ID: 8080853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution to malignancy: A genetic stepwise study of tumor suppressor genes loss in a recurrent meningioma.
    San-Miguel T; Cerdá-Nicolás M; Gil-Benso R; Callaghan RC; Muñoz-Hidalgo L; López-Ginés C
    Clin Neuropathol; 2015; 34(4):237-9. PubMed ID: 25817074
    [No Abstract]   [Full Text] [Related]  

  • 18. Relation of meningiomas to their nearest environment and its significance for recurrence of the tumor.
    Kunicki A
    Neuropatol Pol; 1986; 24(4):511-20. PubMed ID: 3587655
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prognostic factors in meningiomas].
    Figarella-Branger D; Bouvier-Labit C; Liprandi A; Pellissier JF
    Ann Pathol; 2000 Oct; 20(5):438-47. PubMed ID: 11084411
    [No Abstract]   [Full Text] [Related]  

  • 20. The contribution of cytogenetics to the histogenesis of meningeal hemangiopericytoma.
    Zattara-Cannoni H; North MO; Gambarelli D; Figarella-Branger D; Graziani N; Grisoli F; Vagner-Capodano AM
    J Neurooncol; 1996 Aug; 29(2):137-42. PubMed ID: 8858518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.